Summary:
The main objective of this study is to demonstrate the efficacy of intravenous (IV) iron as compared to oral iron in subjects who have IDA.
Qualified Participants Must:
Be 18 years of age or older
Have a hemoglobin level less than 10.0 at screening
Qualified Participants May Receive:
Study medication, physical exams and laboratories at no cost. You may also receive compensation for time and travel.